Stephen Silberstein, MD
Professor
Director, Jefferson Headache Center
Contact
900 Walnut Street
Second Floor
Philadelphia, PA 19107
215-955-2243
215-955-2060 fax
Stephen Silberstein, MD
Professor
Director, Jefferson Headache Center
Research & Clinical Interests
Headache; Migraine; Clinical trials.
Education
Medical School
University of Pennsylvania School of Medicine
Residency
Hospital of University of Pennsylvania (HUP)
Fellowship
National Institute of Health
Publications
- Insights from 25 years of onabotulinumtoxinA in migraine — mechanisms and management
- Clinical factors associated with day-to-day peak pain severity in individuals with chronic migraine: A cohort study using daily prospective diary data
- Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials
- Refractory migraine: a cerebrovascular disease?
- How early can we treat migraine attacks? A perspective based on prodrome
- Developments in targeting calcitonin gene-related peptide
- Evidence-based preventive treatment of migraine ☆
- Drug-Free Noninvasive Thermal Nerve Block: Validation of Sham Devices
- Safety, tolerability, and effectiveness of repetitive intravenous dihydroergotamine for refractory chronic migraine with cardiovascular risk factors: A retrospective study
- Multimodal Migraine Management and the Pursuit of Migraine Freedom: A Narrative Review
- Celecoxib Oral Solution and the Benefits of Self-Microemulsifying Drug Delivery Systems (SMEDDS) Technology: A Narrative Review
- A Novel Virtual-Based Comprehensive Clinical Approach to Headache Care
- Treatment of chronic migraine with Botox (onabotulinumtoxinA): Development, insights, and impact
- Long-term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis
- Adverse Events Reported with Therapies Targeting the CGRP Pathway During the First 6 Months Post-launch: A Retrospective Analysis Using the FDA Adverse Events Reporting System
- Current and emerging pharmacotherapy for menstrual migraine: a narrative review
- Guidelines of the International Headache Society for Clinic-Based Headache Registries, 1st edition
- Lidocaine infusions for refractory chronic migraine: a retrospective analysis
- Efficacy and quality-of-life improvements with fremanezumab treatment in patients with difficult-to-treat migraine with associated neurological dysfunction
- Calcitonin Gene-Related Peptide (CGRP)-Targeted Monoclonal Antibodies and Antagonists in Migraine: Current Evidence and Rationale
Board Certifications
American Board of Psychiatry and Neurology
United Council for Neurological Subspecialities - Headache Medicine
Hospital Appointment
Thomas Jefferson University Hospital
Methodist Hospital Division of Thomas Jefferson University Hospital
Other Expertise
Headache guidelines